<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2019.99162</article-id><article-id pub-id-type="publisher-id">ACM-31923</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20190900000_33792688.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  儿童Gitelman综合征1例并文献复习
  A Case of Gitelman Syndrome in Children and Literature Review
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>高</surname><given-names>媛</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>林</surname><given-names>毅</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>常</surname><given-names>红</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>青岛大学附属医院，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>28</day><month>08</month><year>2019</year></pub-date><volume>09</volume><issue>09</issue><fpage>1055</fpage><lpage>1061</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    目的：本研究报道了1例因反复低钾血症就诊的Gitelman综合征患儿，旨在提高对Gitelman综合征的诊治认识。方法：回顾性分析1例临床疑似Gitelman综合征患儿的临床资料，对患儿进行基因检测明确致病突变，同时查阅文献进行总结分析。结果：患儿临床表现为反复低钾、低镁血症，基因检测结果为SLC12A3基因存在复合杂合突变(c.1456G &gt; A、c.1315G &gt; A)，两者均为致病突变。结论：儿童Gitelman综合征起病隐匿，基因检测发现相关基因致病突变是确诊手段。
    Objective: This study reported a case of patients with Gitelman syndrome due to repeated hypokalemia, in order to improve the understanding of the diagnosis and treatment of Gitelman syndrome. Methods: The clinical data of 1 patient with suspected Gitelman syndrome were retro-spectively analyzed, and the pathogenic mutations were identified by genetic testing. Results: The clinical manifestations of the children were repeated hypokalemia and hypomagnesemia. The ge-netic test results showed that SLC12A3 gene had complex hybrid mutations (c.1456G &gt; a and c.1315G &gt; A), both of which were pathogenic mutations. Conclusion: Gitelman syndrome in children has an insidious onset, and the discovery of related gene pathogenic mutations by genetic testing is a diagnostic method. 
  
 
</p></abstract><kwd-group><kwd>Gitelman综合征，儿童，低钾血症，基因突变, Gitelman Syndrome</kwd><kwd> Children</kwd><kwd> Hypokalemia</kwd><kwd> Genetic Mutations</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>儿童Gitelman综合征1例并文献复习<sup> </sup></title><p>高媛，林毅，常红<sup>*</sup></p><p>青岛大学附属医院，山东 青岛</p><p><img src="//html.hanspub.org/file/2-1571018x1_hanspub.png" /></p><p>收稿日期：2019年8月5日；录用日期：2019年8月21日；发布日期：2019年8月28日</p><disp-formula id="hanspub.31923-formula11"><graphic xlink:href="//html.hanspub.org/file/2-1571018x5_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>目的：本研究报道了1例因反复低钾血症就诊的Gitelman综合征患儿，旨在提高对Gitelman综合征的诊治认识。方法：回顾性分析1例临床疑似Gitelman综合征患儿的临床资料，对患儿进行基因检测明确致病突变，同时查阅文献进行总结分析。结果：患儿临床表现为反复低钾、低镁血症，基因检测结果为SLC12A3基因存在复合杂合突变(c.1456G &gt; A、c.1315G &gt; A)，两者均为致病突变。结论：儿童Gitelman综合征起病隐匿，基因检测发现相关基因致病突变是确诊手段。</p><p>关键词 :Gitelman综合征，儿童，低钾血症，基因突变</p><disp-formula id="hanspub.31923-formula12"><graphic xlink:href="//html.hanspub.org/file/2-1571018x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2019 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/2-1571018x8_hanspub.png" /> <img src="//html.hanspub.org/file/2-1571018x9_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>低钾血症是临床上最常见的电解质紊乱之一，对于不明原因慢性低血钾的儿童，需警惕遗传性肾小管疾病的可能。Gitelman综合征(Gitelman syndrome, GS)是一种遗传性肾小管疾病，又称家族性低钾低镁血症，是一种以低钾血症、低镁血症、低尿钙和代谢性碱中毒为特征的肾脏疾病 [<xref ref-type="bibr" rid="hanspub.31923-ref1">1</xref>]。该疾病在全球各种族均有报道，但因为临床表现隐匿，儿童病例的报道相对较少。本研究报道了2016年于青岛大学附属医院确诊的1例儿童GS病例，旨在提高儿科医师对GS的认识和诊疗水平。</p></sec><sec id="s4"><title>2. 临床资料</title><p>患儿，男性，8岁，因发热、呕吐4天、晕厥1次，发现血钾低半天于2016年10月19日首次入院。患儿入院4天前无明显诱因出现发热，伴有咳嗽，并伴呕吐3次，呈非喷射性，呕吐物为胃内容物。无腹泻，饮食欠佳。病程中晕厥1次，表现为四肢松软，口周发青，呼之不应，无四肢抖动，持续1分钟左右缓解，缓解后精神可，伴有头晕。外院行胸片检查提示为肺炎，予抗感染治疗，效不佳。患儿头晕加重，伴乏力。遂查血电解质示血钾：2 mmol/L，血钙：2.2 mmol/L。予静脉补钾治疗后，为进一步治疗转来我院。患儿自此次发病以来，精神一般、食欲差，小便10余次/天，每次量少，体重无明显减轻。既往有遗尿病史，平素运动能力及体质差，否认长期用药史。智力运动发育正常。家族中无类似疾病史，父母亲均健康，无其他兄弟姐妹。入院查体：体温36.5℃，血压114/60 mmHg，体重22 kg。肤色黑，腹部及臀部多处咖啡牛奶斑。甲状腺不大，双肺呼吸音粗，可闻及中小水泡音，心、腹查体无异常，无手足麻木感，Trousseau征及Chvostek征均阴性。实验室检查提示低血钾、低血镁、代谢性碱中毒，肾素–血管紧张素–血浆醛固酮水平均增高(具体结果见下述图表)；骶尾椎DR正侧位示S1、S2隐形脊柱裂可能；心电图示窦性心律不齐，T波无低平，QRS波无增宽；心脏超声、泌尿系超声无异常。入院予抗感染、止咳平喘及静脉补钾治疗，患儿逐渐进食正常，精神好转。定期复查电解质、肾素–血管紧张素–血浆醛固酮水平，临床症状及血钾正常后好转出院。住院期间外送基因检测，结果未归。</p><p>患儿出院后，规律口服枸橼酸钾(15 ml tid) 1月及螺内酯(10 mg bid)治疗，期间无四肢乏力，遂自行停药。出院1月后患儿又出现高热，伴乏力，无吐泻，抗感染及补钾治疗1天，效不佳，为进一步治疗收住我科。体格检查基本同前，实验室检查提示仍低血钾、低血镁、代谢性碱中毒，高肾素活性及血浆醛固酮水平升高，24小时尿钙0.72 mmol/24h，心电图无明显异常。外送基因检测显示：受检者检出SLC12A3基因有2个错义突变，分别位于两个等位基因，属于复合杂合突变。分别为：1) 位于12号外显子上的c.1456G &gt; A，碱基由G突变为A，编码的氨基酸( p.Asp486Asn; Het)由天冬氨酸替换为天冬酰胺；已有文献报道该突变为中国Gitelman综合征患者的热点突变 [<xref ref-type="bibr" rid="hanspub.31923-ref2">2</xref>]。2) c.1315G&gt;A，碱基由G突变为A，编码的氨基酸(p.Gly439Val; Het)甘氨酸替换为缬氨酸，该突变由国内邵乐平等 [<xref ref-type="bibr" rid="hanspub.31923-ref2">2</xref>] 首次报道。入院抗感染、止咳平喘、静脉及口服补钾、补镁治疗。经治疗后患者血钾、血氯、肾素–血管紧张素–血浆醛固酮水平均恢复至正常水平，患者症状缓解出院。患者两次住院实验室检查结果见下表1、表2、表3所示，基因检测结果见图1所示。</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> The blood electrocyte level of the patient with two admission</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >检测时间</th><th align="center" valign="middle" >血钾</th><th align="center" valign="middle" >血镁</th><th align="center" valign="middle" >血氯</th><th align="center" valign="middle" >血钙</th><th align="center" valign="middle" >血磷</th><th align="center" valign="middle" >血钠</th></tr></thead><tr><td align="center" valign="middle" >第1次入院</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >治疗前</td><td align="center" valign="middle" >2.3</td><td align="center" valign="middle" >0.66</td><td align="center" valign="middle" >93</td><td align="center" valign="middle" >2.22</td><td align="center" valign="middle" >0.94</td><td align="center" valign="middle" >134</td></tr><tr><td align="center" valign="middle" >治疗后</td><td align="center" valign="middle" >3.43</td><td align="center" valign="middle" >0.75</td><td align="center" valign="middle" >98.7</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >138.8</td></tr><tr><td align="center" valign="middle" >第2次入院</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >治疗前</td><td align="center" valign="middle" >3.48</td><td align="center" valign="middle" >0.58</td><td align="center" valign="middle" >101.9</td><td align="center" valign="middle" >2.28</td><td align="center" valign="middle" >1.37</td><td align="center" valign="middle" >140.5</td></tr><tr><td align="center" valign="middle" >治疗后</td><td align="center" valign="middle" >3.87</td><td align="center" valign="middle" >0.72</td><td align="center" valign="middle" >98.6</td><td align="center" valign="middle" >2.35</td><td align="center" valign="middle" >1.81</td><td align="center" valign="middle" >140.4</td></tr></tbody></table></table-wrap><p>表1. 患者两次入院血电解质水平检测结果(mmol/L)</p><p>注：“−”表示未检测；血钾、镁、氯、钙、磷、钠正常值分别为3.5~5.3、0.75~1.02、99~110、2.0~2.7、0.85~1.51和137~147 mmol/L。</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> The blood gas level of the patient with two admission</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >检测时间</th><th align="center" valign="middle" >HCO 3 −</th><th align="center" valign="middle" >PaCO<sub>3</sub></th><th align="center" valign="middle" >TCO2</th><th align="center" valign="middle"  rowspan="2"  >PH</th></tr></thead><tr><td align="center" valign="middle" >(mmol/L)</td><td align="center" valign="middle" >(mm Hg)</td><td align="center" valign="middle" >(mmol/L)</td></tr><tr><td align="center" valign="middle" >第1次入院</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >治疗前</td><td align="center" valign="middle" >27.9</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >7.51</td></tr><tr><td align="center" valign="middle" >治疗后</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td></tr><tr><td align="center" valign="middle" >第2次入院</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >治疗前</td><td align="center" valign="middle" >29.1</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >30.3</td><td align="center" valign="middle" >7.47</td></tr><tr><td align="center" valign="middle" >治疗后</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td></tr></tbody></table></table-wrap><p>表2. 患者两次入院血气分析结果</p><p>注：“−”表示未检测；血气分析结果中 HCO 3 − 、PaCO<sub>2</sub>、TCO<sub>2</sub>、pH正常值分别为21.3~24.8 mmol/L、80~100 mm Hg、24.0~32.0 mmol/L、7.35~7.45。</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> The renin-angiotensin-plasma aldosterone leve</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >检测时间</th><th align="center" valign="middle" >肾素活性(卧位)/</th><th align="center" valign="middle" >肾素活性(立位)/</th><th align="center" valign="middle" >血管紧张素II</th><th align="center" valign="middle" >血管紧张素II</th><th align="center" valign="middle" >醛固酮(卧位)/</th><th align="center" valign="middle" >醛固酮(立位)/</th></tr></thead><tr><td align="center" valign="middle" >［ng/(ml&#183;h)］</td><td align="center" valign="middle" >［ng/(ml&#183;h)］</td><td align="center" valign="middle" >(卧位)/(pg/ml)</td><td align="center" valign="middle" >(立位)/(pg/ml)</td><td align="center" valign="middle" >(pg/ml)</td><td align="center" valign="middle" >(pg/ml)</td></tr><tr><td align="center" valign="middle" >第1次入院</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >治疗前</td><td align="center" valign="middle" >1.32</td><td align="center" valign="middle" >6.51</td><td align="center" valign="middle" >158.92</td><td align="center" valign="middle" >112.67</td><td align="center" valign="middle" >285.9</td><td align="center" valign="middle" >274.93</td></tr><tr><td align="center" valign="middle" >治疗后</td><td align="center" valign="middle" >8.84</td><td align="center" valign="middle" >12.43</td><td align="center" valign="middle" >191</td><td align="center" valign="middle" >159.08</td><td align="center" valign="middle" >209.93</td><td align="center" valign="middle" >325.96</td></tr><tr><td align="center" valign="middle" >第2次入院</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr></tbody></table></table-wrap><p>表3. 肾素–血管紧张素–血浆醛固酮水平</p><p>注：“－”表示未检测；肾素活性(卧位)、肾素活性(立位)、血管紧张素II (卧位)、血管紧张素II (立位)、醛固酮(卧位)、醛固酮(立位)正常值分别为0.15~2.33 ng/(ml&#183;h)、0.10~6.56 ng/(ml&#183;h)、25.0~60.0 pg/ml、50.0~120.0 pg/ml、30~160 pg/ml、70~300 pg/ml。</p><p>图1. Gitelman综合征患儿及其父母的基因突变图</p></sec><sec id="s5"><title>3. 讨论</title><p>本报道中患儿多次出现晕厥及乏力表现，且多次血生化检查提示低钾血症及代谢性碱中毒。结合患儿年龄，考虑Bartter综合征(Bartter syndrome, BS)或GS可能性大。病程中患儿无明显诱因出现晕厥1次，且查体时发现患儿躯干部有牛奶咖啡斑样皮疹，不除外神经系统疾病，完善脑电图检查及颅脑磁共振检查，可初步排除神经系统疾病，考虑晕厥原因与电解质紊乱有关。</p><p>结合该患儿病史，应明确低钾血症原因。其诊断思路如下：1) 低钾血症为慢性还是急性：该患儿既往未行电解质检查，无确切证据证实其存在慢性低钾。但患儿平素体质差、易乏力，体格发育落后，近期多次查血提示低钾血症，且呕吐、饮食差时症状加重并伴有晕厥，考虑慢性低钾急性加重可能性大。2) 低钾的原因：a) 摄入不足：因为钾主要存在于细胞内，血钾有很大的储备，故摄入不足所致的低钾血症主要由长期摄入不足引起。患儿仅在病程中出现一过性呕吐，且平素无特殊饮食习惯，不足以引起如此显著的低钾血症。故可排除摄入不足所致低血钾。b) 代谢性疾病：胰岛素可促进血钾与葡萄糖同步向细胞内转运。故如有高胰岛素血症，或医源性使用胰岛素，可能引起低钾血症。但在该患儿，并无高胰岛素血症存在的证据，可排除。c) 丢失过多：肠液中含有大量的钾，在严重腹泻时可因显著失钾造成低钾血症。另外，一部分钾可从尿中排出。该患儿此次病程中无腹泻，排除消化道丢失可能。因此考虑患儿尿中丢失可能性大。尿中电解质的水平主要由肾小管调节。GS和BS是儿童最常见的失盐性肾小管疾病。结合患儿病史，从低钾血症成因角度分析，GS及BS可能性最大。根据临床表型及发病机制不同，BS被分为新生儿型(BSI型及BSII型)、经典型(BSIII型)、新生儿型伴感音性耳聋(BSIV型)、Bartter综合征合并常染色体显性遗传性低血钙型(BSV型) [<xref ref-type="bibr" rid="hanspub.31923-ref3">3</xref>]。BS是因髓袢升支粗段(TAL)功能障碍导致的肾小管失盐性疾病，而GS是因远曲小管(DCT)重吸收氯化钠功能障碍所致的肾小管失盐性疾病。其中GS与经典型BS的临床表现较难鉴别，有一定的重合。GS患儿一般发病年龄晚，病情轻，预后好 [<xref ref-type="bibr" rid="hanspub.31923-ref4">4</xref>]；临床表现为头晕、乏力、呕吐、腹痛、发热、夜尿增多及多尿，生长发育一般不受影响 [<xref ref-type="bibr" rid="hanspub.31923-ref5">5</xref>]，血压通常正常。低镁血症状为GS所特有，是与BS鉴别的最重要的临床依据 [<xref ref-type="bibr" rid="hanspub.31923-ref6">6</xref>]。BS患儿一般血镁正常。结合患儿实验室检查提示存在低镁血症，故GS可能性大。当然，基因检测才是鉴别两者的最终手段。</p><p>根据2017年国内肾脏病相关专家小组发布的《Gitelman综合征诊治专家共识》 [<xref ref-type="bibr" rid="hanspub.31923-ref7">7</xref>]，目前支持GS诊断指标如下：① 慢性低钾血症(血清钾 &lt; 3.5 mmol/L，排除使用降钾类药物)合并肾脏排钾增多(随机尿中尿钾/尿肌酐 &gt; 2 mmol/mmol)；② 代谢性碱中毒；③ 低镁血症(血镁 &lt; 0.7 mmol/L)伴肾脏排镁增多(镁排泄分数 &gt; 4%)；④ 低尿钙症(成人随机尿中尿钙/尿肌酐 &lt; 0.2 mmol/mmol)；⑤ 血浆肾素水平或活性增高；⑥ 氯离子排泄分数 &gt; 0.5%；⑦ 正常或偏低的血压；⑧ 正常的肾脏超声表现。该文献指出其确诊标准是：SLC12A3基因中发现两个致病突变。目前越来越多文献报道，GS患者血清镁可表现正常。结合患儿临床表现及辅助检查，符合上述①②③④⑤⑦⑧ 7条指标，同时该患儿基因检测结果为SLC12A3基因中存在复合杂合突变，明确诊断为GS。</p><p>GS是一种常染色体隐性遗传疾病，其发病基础是由于编码噻嗪类利尿剂敏感的钠氯共同转运体(NCCT)的16号染色体长臂上SLC12A3基因突变 [<xref ref-type="bibr" rid="hanspub.31923-ref8">8</xref>]，针对该基因通过基因敲入和基因敲除的方法已成功制造出GS小鼠模型的报道，证实了其病因所在 [<xref ref-type="bibr" rid="hanspub.31923-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.31923-ref10">10</xref>]。SLC12A3基因突变导致其编码的表达于远曲小管上皮细胞的NCCT结构和(或)功能障碍，后者引起远曲小管的钠氯重吸收的障碍导致低血容量，诱发肾素–血管紧张素–醛固酮系统激活、低血钾、代谢性碱中毒，伴随电化学的改变使钙离子重吸收增加，同时镁离子通道(TRPM6)数量下降 [<xref ref-type="bibr" rid="hanspub.31923-ref11">11</xref>]，使镁离子重吸收减少，引起低血镁。根据2014年人类基因组数据库的数据显示，目前已经发现的GS致病突变共有425种，以错义突变最为常见；大多数患者为复合杂合突变，纯合突变少见 [<xref ref-type="bibr" rid="hanspub.31923-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.31923-ref13">13</xref>]。在汉族人目前已发现的40多种突变中，错义突变为最主要的突变类型；其他突变类型，如无义突变、移框和剪切位点突变也有发现，但相对较少。突变位点在整个蛋白分子均有分布 [<xref ref-type="bibr" rid="hanspub.31923-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.31923-ref15">15</xref>]。在中国人群中，p.T60M和p.D486N是常见的突变位点 [<xref ref-type="bibr" rid="hanspub.31923-ref16">16</xref>] [<xref ref-type="bibr" rid="hanspub.31923-ref17">17</xref>]。</p><p>GS具有高度遗传异质性，临床表型多样。研究发现发病年龄越小，临床表现越重。已有文献报道性别可能决定了GS的严重程度 [<xref ref-type="bibr" rid="hanspub.31923-ref5">5</xref>]，有学者对比了不同性别GS患者的临床表现，发现男性患者低血钾程度比女性患者更加严重 [<xref ref-type="bibr" rid="hanspub.31923-ref18">18</xref>]。同时国外已有文献报道对患有GS的日本人群的研究中发现具有热点突变的患者血清镁水平明显增高 [<xref ref-type="bibr" rid="hanspub.31923-ref19">19</xref>]。GS表型的异质性不仅表现在不同的个体，即使相同的突变，表型也不一样。目前仍缺乏大样本流行病学资料证实基因型与表型的关系，需进一步研究。</p><p>GS可合并全身多个系统疾病，目前报道最多的是合并心血管系统、泌尿系统及内分泌系统相关疾病，少有报道合并神经系统疾病，具体发病机制可能与低血钾及低血镁相关。已有文献报道GS可合并小脑共济失调 [<xref ref-type="bibr" rid="hanspub.31923-ref20">20</xref>]，临床表现可伴有癫痫发作，部分研究发现此类患儿低血镁纠正后，癫痫发作次数明显减少 [<xref ref-type="bibr" rid="hanspub.31923-ref21">21</xref>]。但仍有学者发现此类患儿血镁水平可显示正常 [<xref ref-type="bibr" rid="hanspub.31923-ref22">22</xref>]。因此，GS患儿出现癫痫发作的病理机制仍待研究。GS可合并多种类型心血管疾病，其发病机制可能是低血钾可通过影响心肌细胞电化学改变，从而导致患儿心电图可出现多种改变，严重者可出现心室颤动。GS合并泌尿系统疾病中，主要表现为肾小球疾病，如局灶性节段性肾小球硬化症 [<xref ref-type="bibr" rid="hanspub.31923-ref23">23</xref>] 、肾小球肾炎，其病理机制可能是由于RAAS系统持续激活、长期低钾血症、肾脏钙盐沉积 [<xref ref-type="bibr" rid="hanspub.31923-ref24">24</xref>]。GS合并内分泌相关疾病中，身材矮小症最常见，主要表现为生长迟缓 [<xref ref-type="bibr" rid="hanspub.31923-ref25">25</xref>] [<xref ref-type="bibr" rid="hanspub.31923-ref26">26</xref>] 或精神发育迟滞 [<xref ref-type="bibr" rid="hanspub.31923-ref21">21</xref>]，其机制可能是低钾对生长激素的分泌起负性调节作用，且低钾可导致生长激素、IGF-I组织特异性改变。2012年，国内首次报道因矮身材就诊，后明确诊断为GS [<xref ref-type="bibr" rid="hanspub.31923-ref27">27</xref>]。其次有研究报道GS可合并2型糖尿病，其机制可能是慢性低镁血症可引起细胞葡萄糖转运改变、胰岛素分泌异常、胰岛素受体后信号传导障碍、胰岛素–胰岛素受体相互作用改变，多种因素诱发胰岛素抵抗，最终引起糖尿病 [<xref ref-type="bibr" rid="hanspub.31923-ref28">28</xref>]。另外，低钾血症也可导致生物活性胰岛素分泌受损，以及不明原因导致的胰岛素抵抗 [<xref ref-type="bibr" rid="hanspub.31923-ref29">29</xref>]，且糖尿病发病年龄也更早 [<xref ref-type="bibr" rid="hanspub.31923-ref30">30</xref>] [<xref ref-type="bibr" rid="hanspub.31923-ref31">31</xref>]。亦有文献报道，GS患儿可出现甲状腺功能障碍，包括甲状腺功能亢进及甲状腺功能低下。获得性GS极为罕见，儿童未见报道。成人仅报告3例，一例继发于肾移植术后，一例继发于干燥综合征，一例继发于系统性硬化症 [<xref ref-type="bibr" rid="hanspub.31923-ref32">32</xref>]。</p><p>GS患儿治疗主要以纠正电解质紊乱为主，建议血钾和血镁的治疗目标分别为3.0 mmo/L和0.6 mmol/L [<xref ref-type="bibr" rid="hanspub.31923-ref33">33</xref>]。补钾治疗首先选用氯化钾，口服为主，不耐受或血钾补水平极低者应静脉补钾。推荐儿童起始剂量为1~2 mmol/kg.d，每日餐后分次服用。关于补镁治疗，国外建议应用氯化镁，同时补充尿氯的丢失；国内推荐应用门冬氨酸钾镁。口服补镁推荐儿童起始剂量为5 mg/kg.d，缓释剂型效佳，每日2~4次随餐服用。患儿出现严重低镁血症并发症时，可静脉输注20%氯化镁(每次0.1 mmol/kg)，必要时可6 h重复一次。对于补镁后仍无法纠正低钾症状的患者，治疗以补钾、保钾为主。补钾治疗效果不好的患者，可联合应用醛固酮拮抗剂、肾素–血管紧张素阻断剂或非甾体抗炎药，一般从小剂量开始(具体用药方式及剂量未见文献报道)。需注意其不良反应，避免加重病情。同时加强患者教育和管理也非常重要。GS患者在儿童时期预后良好。本报道中该患儿出院后定期随访，各项实验室检查指标均维持在安全范围内，同时该病例报道已获得患儿家属的知情同意。</p><p>总之，对于临床中不明原因低钾血症的患儿，应详细询问病史，完善相关辅助检查，明确诊断，务必做到早发现，早诊断，早治疗。</p></sec><sec id="s6"><title>文章引用</title><p>高 媛,林 毅,常 红. 儿童Gitelman综合征1例并文献复习A Case of Gitelman Syndrome in Children and Literature Review[J]. 临床医学进展, 2019, 09(09): 1055-1061. https://doi.org/10.12677/ACM.2019.99162</p></sec><sec id="s7"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.31923-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Graziani, G., Fedeli, C., Moroni, L., Cosmai, L., Badalamenti, S. and Ponticelli, C. (2010) Gitelman Syndrome: Path-ophysiological and Clinical Aspects. QJM: An International Journal of Medicine, 103, 741-748.  
&lt;br&gt;https://doi.org/10.1093/qjmed/hcq123</mixed-citation></ref><ref id="hanspub.31923-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Shao, L., Ren, H., Wang, W., Zhang, W., Feng, X., Li, X. and Chen, N. (2008) Novel SLC12A3 Mutations in Chinese Patients with Gitelman’s Syndrome. Nephron Physiology, 108, 29-36. &lt;br&gt;https://doi.org/10.1159/000117815</mixed-citation></ref><ref id="hanspub.31923-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">郭琴, 张翀. 低钾失盐性肾小管病的研究进展[J]. 上海交通大学学报(医学版), 2018, 38(9): 1109-1115.</mixed-citation></ref><ref id="hanspub.31923-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Cruz, D.N., Shaer, A.J., Bia, M.J., Lifton, R.P. and Simon, D.B. (2001) Gitelman’s Syndrome Revisited: An Evaluation of Symptoms and Health-Related Quality of Life. Kidney International, 59, 710-717.  
&lt;br&gt;https://doi.org/10.1046/j.1523-1755.2001.059002710.x</mixed-citation></ref><ref id="hanspub.31923-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Riveira-Munoz, E., Chang, Q., Godefroid, N., et al. (2007) Transcriptional and Functional Analyses of SLC12A3 Mutations: New Clues for the Pathogenesis of Gitelman Syndrome. Journal of the American Society of Nephrology, 18, 1271-1283. &lt;br&gt;https://doi.org/10.1681/ASN.2006101095</mixed-citation></ref><ref id="hanspub.31923-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Pantanetti, P., Arnaldi, G., Balercia, G., Mantero, F. and Giacchetti, G. (2002) Severe Hypomagnesaemia-Induced Hypocalcaemia in a Patient with Gitelman’s Syndrome. Clinical Endocrinology, 56, 413-418. 
&lt;br&gt;https://doi.org/10.1046/j.1365-2265.2002.01223.x</mixed-citation></ref><ref id="hanspub.31923-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Gitelman综合征诊治专家共识协作组. Gitelman综合征诊治专家共识[J]. 中华内科杂志, 2017, 56(9): 712-716.</mixed-citation></ref><ref id="hanspub.31923-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Melander, O., Orho-Melander, M., Bengtsson, K., et al. (2000) Genetic Variants of Thiazide-Sensitive NaCl-Cotransporter in Gitelman’s Syndrome and Primary Hypertension. Hypertension, 36, 389-394. 
&lt;br&gt;https://doi.org/10.1161/01.HYP.36.3.389</mixed-citation></ref><ref id="hanspub.31923-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Yang, S.S., Lo, Y.F., Yu, I.S., et al. (2010) Generation and Analy-sis of the Thiazide-Sensitive Na+-Cl- Cotransporter (Ncc/Slc12a3) Ser707X Knockin Mouse as a Model of Gitelman Syndrome. Human Mutation, 31, 1304-1315. 
&lt;br&gt;https://doi.org/10.1002/humu.21364</mixed-citation></ref><ref id="hanspub.31923-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Yang, S.S., Lo, Y.F., Wu, C.C., et al. (2010) SPAK-Knockout Mice Manifest Gitelman Syndrome and Impaired Vasoconstriction. Journal of the American Society of Nephrology, 21, 1868-1877.  
&lt;br&gt;https://doi.org/10.1681/ASN.2009121295</mixed-citation></ref><ref id="hanspub.31923-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Daan, V., de Baaij, J.H.F., Walsh, S.B., Kleta, R. and Bockenhauer, D. (2017) Genetic Causes of Hypomagnesemia, a Clinical Overview. Pediatric Nephrology, 32, 1123-1135. &lt;br&gt;https://doi.org/10.1007/s00467-016-3416-3</mixed-citation></ref><ref id="hanspub.31923-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Luo, J., Yang, X., Liang, J. and Li, W. (2015) A Pedigree Anal-ysis of Two Homozygous Mutant Gitelman Syndrome Cases. Endocrine Journal, 62, 29-36.</mixed-citation></ref><ref id="hanspub.31923-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Vargas-Poussou, R., Dahan, K., Kahila, D., et al. (2011) Spectrum of Mutations in Gitelman Syndrome. Journal of the American Society of Nephrology, 22, 693-703. &lt;br&gt;https://doi.org/10.1681/ASN.2010090907</mixed-citation></ref><ref id="hanspub.31923-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Glaudemans, B., Yntema, H.G., San-Cristobal, P., et al. (2012) Novel NCC Mutants and Functional Analysis in a New Cohort of Patients with Gitelman Syndrome. European Journal of Human Genetics, 20, 263-270.  
&lt;br&gt;https://doi.org/10.1038/ejhg.2011.189</mixed-citation></ref><ref id="hanspub.31923-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">董晖, 郎艳华, 邵泽平, 李林, 邵乐平. Gitelman综合征合并甲状腺疾病: 两例患者SLC12A3基因分析[J]. 中华内分泌代谢杂志, 2010, 26(5): 395-398.</mixed-citation></ref><ref id="hanspub.31923-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">邵乐平, 逯静茹, 郎艳华, 周丽敏, 王翠, 刘婷. 中国Gitelman综合征患者的基因型、表型分析及随访研究[J]. 中华内分泌代谢杂志, 2017, 33(1): 40-46.</mixed-citation></ref><ref id="hanspub.31923-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Wang, F., Shi, C., Cui, Y., Li, C. and Tong, A. (2017) Mutation Profile and Treatment of Gitelman Syndrome in Chinese Patients. Clinical and Experimental Nephrology, 21, 293-299. &lt;br&gt;https://doi.org/10.1007/s10157-016-1284-6</mixed-citation></ref><ref id="hanspub.31923-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Jiang, L., Chen, C., Yuan, T., et al. (2014) Clinical Severity of Gitelman Syndrome Determined by Serum Magnesium. American Journal of Nephrology, 39, 357-366. &lt;br&gt;https://doi.org/10.1159/000360773</mixed-citation></ref><ref id="hanspub.31923-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Fujimura, J., Nozu, K., Yamamura, T., et al. (2019) Clinical and Genetic Characteristics in Patients With Gitelman Syndrome. Kidney International Reports, 4, 119-125. &lt;br&gt;https://doi.org/10.1016/j.ekir.2018.09.015</mixed-citation></ref><ref id="hanspub.31923-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Gokalp, C., Cetin, C., Bedir, S. and Duman, S. (2019) Gitelman Syndrome Presenting with Cerebellar Ataxia: A Case Report. Acta Neurologica Belgica, 1-3. &lt;br&gt;https://doi.org/10.1007/s13760-019-01095-6</mixed-citation></ref><ref id="hanspub.31923-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Shao, L., Liu, L., Miao, Z., et al. (2008) A Novel SLC12A3 Splicing Mutation Skipping of Two Exons and Preliminary Screening for Alternative Splice Variants in Human Kidney. American Journal of Nephrology, 28, 900-907.  
&lt;br&gt;https://doi.org/10.1159/000141932</mixed-citation></ref><ref id="hanspub.31923-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Shahzad, M.A., Mukhtar, M., Ahmed, A., Ullah, W., Saeed, R. and Hamid, M. (2019) Gitelman Syndrome: A Rare Cause of Seizure Disorder and a Systematic Review. Case Reports in Medicine, 2019, Article ID: 4204907.  
&lt;br&gt;https://doi.org/10.1155/2019/4204907</mixed-citation></ref><ref id="hanspub.31923-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Ceri, M., Unverdi, S., Altay, M., et al. (2011) Focal Segmental Glo-merulosclerosis in Association with Gitelman Syndrome. International Urology and Nephrology, 43, 905-907. &lt;br&gt;https://doi.org/10.1007/s11255-010-9802-z</mixed-citation></ref><ref id="hanspub.31923-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">梁丹丹, 曾彩虹. Gitelman综合征肾脏损害[J]. 肾脏病与透析肾移植杂志, 2016, 25(3): 291-295.</mixed-citation></ref><ref id="hanspub.31923-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Conti, G., Vitale, A., Tedeschi, S., et al. (2010) Hypokalaemia and Failure to Thrive: Report of a Misleading Onset. Journal of Paediatrics and Child Health, 46, 276-277. &lt;br&gt;https://doi.org/10.1111/j.1440-1754.2009.01684.x</mixed-citation></ref><ref id="hanspub.31923-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Tuhta, G.A., Tuhta, A. and Erdogan, M. (2010) Gitelman Syndrome with Mental Retardation: A Case Report. Journal of Nephrology, 23, 617-618.</mixed-citation></ref><ref id="hanspub.31923-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">王晴晴, 王新利. 以矮身材为主要表现的Gitelman综合征1例报告[J]. 中国当代儿科杂志, 2012, 14(8): 637-638.</mixed-citation></ref><ref id="hanspub.31923-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">王欣, 刘如, 张慧英. 低血镁与糖代谢的相关性研究[J]. 内蒙古医科大学学报, 2015, 37(4): 397-401.</mixed-citation></ref><ref id="hanspub.31923-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Azak, A., Huddam, B., Koçak, G., Ortabozkoyun, L., Uzel, M. and Duranay, M. (2011) Gitelman Syndrome Complicated with Dysglycemia. Acta Diabetologica, 48, 249-250. &lt;br&gt;https://doi.org/10.1007/s00592-011-0277-x</mixed-citation></ref><ref id="hanspub.31923-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Wong, K.C. and Wang, Z. (2006) Prevalence of Type 2 Diabetes Mellitus of Chinese Populations in Mainland China, Hong Kong, and Taiwan. Diabetes Research and Clinical Practice, 73, 126-134.  
&lt;br&gt;https://doi.org/10.1016/j.diabres.2006.01.007</mixed-citation></ref><ref id="hanspub.31923-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Huo, X., Gao, L., Guo, L., et al. (2016) Risk of Non-Fatal Cardiovascular Diseases in Early-Onset versus Late-Onset Type 2 Diabetes in China: A Cross-Sectional Study. The Lancet Diabetes &amp; Endocrinology, 4, 115-124.</mixed-citation></ref><ref id="hanspub.31923-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Masab, M., Goyal, A., Abrol, S. and Rangaswami, J. (2019) Ac-quired Gitelman Syndrome Associated with Systemic Sclerosis. Cureus, 11, e3923. &lt;br&gt;https://doi.org/10.7759/cureus.3923</mixed-citation></ref><ref id="hanspub.31923-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Blanchard, A., Bockenhauer, D., Bolignano, D., et al. (2017) Gitelman Syndrome: Consensus and Guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 91, 24-33. 
&lt;br&gt;https://doi.org/10.1016/j.kint.2016.09.046</mixed-citation></ref></ref-list></back></article>